Erectile Dysfunction Drugs Don’t Cause Eye Damage

Men using erectile dysfunction drugs face no risk for vision problems, according to a study in the...

» read full story

April 14th, 2009 - 14:59

FDA Warns 14 Drugmakers for “Misleading” Ads on the Internet

The Food and Drug Administration on Friday faulted 14 pharmaceutical companies for...

» read full story

April 04th, 2009 - 22:31

Eli Lilly’s Symbyax Gets FDA Approval for Treatment-Resistant Depression

The US Food and Drug Administration has approved Eli Lilly’s Symbyax, a combination of...

» read full story

March 23rd, 2009 - 20:25

FDA Wants Additional Data for Head and Neck Cancer Drug Erbitux

The Food and Drug Administration have declined to approve use of Erbitux as a first-line...

» read full story

March 03rd, 2009 - 18:03

Lilly, Daiichi Blood Thinner Prasugrel Gets European Approval

The European Commission on Monday gave its approval for blood-thinning drug Efient for heart...

» read full story

February 24th, 2009 - 14:36

Erbitux Plus Other Cancer Drugs Not Helpful for Colorectal Cancer

A Dutch study published in the Feb. 5 issue of the New England Journal of Medicine reveals that...

» read full story

February 05th, 2009 - 14:58

Panel Unanimously Votes For Lilly, Daiichi Blood Thinner Prasugrel

An advisory panel of the US Food and Drug Administration on Tuesday voted unanimously to...

» read full story

February 04th, 2009 - 14:59

FDA Panel Backs Ely Lilly’s Blood Thinner Prasugrel

Blood thinner prasugrel, made by Eli Lilly and Co. in a joint with Daiichi Sankyo Co., Ltd., is...

» read full story

February 02nd, 2009 - 15:12

Addictive Painkiller Finally Withdrawn by the FDA

An advisory panel to the Food and Drug Administration voted 14 to 12 to recommend the withdrawal of...

» read full story

January 31st, 2009 - 22:07

FDA Panel Votes to Ban Darvon Painkiller

Government advisers suggested a ban on the Darvon painkiller which has been in...

» read full story

January 31st, 2009 - 14:38

FDA Approves of Lilly, Daiichi Anti-Clot Drug

  Friday, the Food and Drug Administration gave the go-ahead to Eli Lilly and Company’s...

» read full story

January 30th, 2009 - 20:27

FDA To Approve Eli Lilly’s Anti-Clotting Drug Prasugrel

The Food and Drug Administration is expected to approve Eli Lilly and Co.’s and Daiichi...

» read full story

January 30th, 2009 - 16:36

Ely Lilly Settles For More Than $800 Million In Zyprexa Lawsuit

  Eli Lilly and Co. has agreed to pay approximately $800 million for unapproved marketing and...

» read full story

January 21st, 2009 - 16:06

Newer Antipsychotics Increase Heart Risk

The latest generation of antipsychotic drugs appears to be twice as likely to cause sudden...

» read full story

January 15th, 2009 - 12:52

FDA Delays Decision About Zyprexa

Eli Lilly & Co. has announced on Wednesday that the Food and Drug Administration (FDA) is...

» read full story

January 09th, 2009 - 14:13

FDA Refuses To Approve Lilly’s Long-Acting Zyprexa

  The US Food and Drug Administration refused to immediately approve a long-acting...

» read full story

January 08th, 2009 - 14:00

FDA Panel Meeting For Reviewing Prasugrel

An FDA advisory panel will review the blood-cloth preventer prasugrel, according to maker Daiichi...

» read full story

December 31st, 2008 - 17:43

FDA Wants More Study for Diabetes Drugs to Better Asses for Heart Risks

More than a year after GlaxoSmithKline PLC’s Avandia was linked to higher risk of heart...

» read full story

December 18th, 2008 - 13:34

Harvard’s Renowned Psychiatrist under Investigation for Drug Earnings

A Congressional investigation led by Sen. Charles Grassley revealed in June that a world-renowned...

» read full story

November 25th, 2008 - 14:21

Leading Emory Psychiatrist ‘Fails’ to Report $1.2 Million of Drug Income

Emory University psychiatrist Charles Nemeroff has been accused of not reporting almost half of the...

» read full story

October 04th, 2008 - 19:54

Another Chance in Fighting Non-Small Cell Lung Cancer

The drug maker Eli Lilly announced the U.S. Food and Drug Administration (FDA) has approved the...

» read full story

September 29th, 2008 - 23:36

Both Newer and Older-Generation Antipsychotics Have Side Effects

It appears that newer antipsychotics, such as Zyprexa from Eli Lilly and Risperdal from Janssen...

» read full story

September 16th, 2008 - 14:59

Newer Antipsychotics Put Children At Greater Risks Than Older Ones

New research by the National Institutes of Health’s National Institute of Mental Health published...

» read full story

September 15th, 2008 - 16:33

Study: Byetta Is Better Than Januvia At Lowering Glucose Levels

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced that a randomized, double-blind,...

» read full story

September 09th, 2008 - 20:43

Byetta Does Better Than Januvia In Trial

A twice-daily version of the popular Byetta diabetes treatment showed more efficiency for...

» read full story

September 09th, 2008 - 18:58

Update: Pfizer Is Seeking FDA’s Approval For Osteoporosis Drug

Pfizer, the world’s biggest drugmaker, is seeking U.S. Food and Drug Administration approval for...

» read full story

September 09th, 2008 - 14:30

Pfizer’s Osteoporosis Treatment Under FDA Analysis

Today, Pfizer Incorporated appeared for the third time before Federal Drug Administration medical...

» read full story

September 08th, 2008 - 23:12

Potential Problem Drugs Listed By the FDA

Food and Drug Administration officials announced Friday that they will begin posting a list of...

» read full story

September 06th, 2008 - 16:28

FDA Seeks Pancreatitis Warning for Diabetes Drug Byetta

The Food and Drug Administration on Monday announced that it’s seeking a stronger, more prominent...

» read full story

August 19th, 2008 - 13:30

FDA Warns About Risks Linked With Older Antipsychotics

The U.S. Food and Drug Administration on Monday warned physicians that prescribing certain...

» read full story

June 17th, 2008 - 15:12

Newer Antipsychotics Double Heart Risks

The latest generation of antipsychotic drugs appears to be twice as likely to cause sudden...

» read full story

January 16th, 2009 - 11:48

FDA Requires More Study Of Heart Risk For Diabetes Drugs

More than a year after GlaxoSmithKline PLC’s Avandia was linked to higher risk of heart...

» read full story

December 18th, 2008 - 20:21

FDA Wants 14 Drugmakers to Stop Misleading Ads

The Internet is full of promotional ads of drugs and I am sure you thought at least once in your...

» read full story

April 05th, 2009 - 22:48

Daiichi, Lilly Get European Approval for Prasugrel

  Monday, Eli Lilly & Company and Daiichi Sankyo Company announced that they had earned...

» read full story

February 23rd, 2009 - 21:23

FDA Advisory Panel Recommends Banning Painkiller Darvon

  FDA advisers have recommended that Darvon, a commonly prescribed painkiller, should be...

» read full story

February 02nd, 2009 - 15:30

Blood-Cloth Preventer Prasugrel To Be Reviewed

The U.S. Food and Drug Administration said it needs more time to review Eli Lilly and Co.'s...

» read full story

January 01st, 2009 - 15:24

Another Cure for Cancer Approved by FDA

Eli Lilly and Co. announced on Monday that the Food and Drug Administration has approved the use of...

» read full story

September 29th, 2008 - 23:39

Byetta Outruns Rival Januvia in Diabetes Trial

Eli Lilly and Co and Amylin Pharmaceuticals Inc’s diabetes drug Byetta proved better at reducing...

» read full story

September 10th, 2008 - 15:20

Eli Lilly’s Symbyax Approved By FDA For TRD Treatment

Eli Lilly’s Symbyax won FDA’s approval for the treatment of treatment-resistant...

» read full story

March 23rd, 2009 - 18:04

Amylin Shares Drop as FDA Warns about Byetta’s Pancreatitis Risk

The United States Food and Drug Administration issued Monday warnings to doctors and patients as...

» read full story

August 19th, 2008 - 15:49